These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
175 related articles for article (PubMed ID: 33663367)
41. Bioactivity Potential of Marine Natural Products from Scleractinia-Associated Microbes and In Silico Anti-SARS-COV-2 Evaluation. Zahran EM; Albohy A; Khalil A; Ibrahim AH; Ahmed HA; El-Hossary EM; Bringmann G; Abdelmohsen UR Mar Drugs; 2020 Dec; 18(12):. PubMed ID: 33339096 [TBL] [Abstract][Full Text] [Related]
42. The Potential of Algal Biotechnology to Produce Antiviral Compounds and Biopharmaceuticals. Rosales-Mendoza S; García-Silva I; González-Ortega O; Sandoval-Vargas JM; Malla A; Vimolmangkang S Molecules; 2020 Sep; 25(18):. PubMed ID: 32899754 [TBL] [Abstract][Full Text] [Related]
43. Ten-Year Research Update Review: Antiviral Activities from Marine Organisms. Riccio G; Ruocco N; Mutalipassi M; Costantini M; Zupo V; Coppola D; de Pascale D; Lauritano C Biomolecules; 2020 Jul; 10(7):. PubMed ID: 32645994 [TBL] [Abstract][Full Text] [Related]
44. Natural products and phytochemicals as potential anti-SARS-CoV-2 drugs. Merarchi M; Dudha N; Das BC; Garg M Phytother Res; 2021 Oct; 35(10):5384-5396. PubMed ID: 34132421 [TBL] [Abstract][Full Text] [Related]
45. Current approaches for target-specific drug discovery using natural compounds against SARS-CoV-2 infection. Khare P; Sahu U; Pandey SC; Samant M Virus Res; 2020 Dec; 290():198169. PubMed ID: 32979476 [TBL] [Abstract][Full Text] [Related]
46. Propolis efficacy on SARS-COV viruses: a review on antimicrobial activities and molecular simulations. Ghosh S; Al-Sharify ZT; Maleka MF; Onyeaka H; Maleke M; Maolloum A; Godoy L; Meskini M; Rami MR; Ahmadi S; Al-Najjar SZ; Al-Sharify NT; Ahmed SM; Dehghani MH Environ Sci Pollut Res Int; 2022 Aug; 29(39):58628-58647. PubMed ID: 35794320 [TBL] [Abstract][Full Text] [Related]
47. In silico evaluation of COVID-19 main protease interactions with honeybee natural products for discovery of high potential antiviral compounds. Zarei A; Ramazani A; Pourmand S; Sattari A; Rezaei A; Moradi S Nat Prod Res; 2022 Aug; 36(16):4254-4260. PubMed ID: 34498974 [TBL] [Abstract][Full Text] [Related]
48. Antiviral Activity of Type I, II, and III Interferons Counterbalances ACE2 Inducibility and Restricts SARS-CoV-2. Busnadiego I; Fernbach S; Pohl MO; Karakus U; Huber M; Trkola A; Stertz S; Hale BG mBio; 2020 Sep; 11(5):. PubMed ID: 32913009 [TBL] [Abstract][Full Text] [Related]
49. The vital role of animal, marine, and microbial natural products against COVID-19. Alqathama AA; Ahmad R; Alsaedi RB; Alghamdi RA; Abkar EH; Alrehaly RH; Abdalla AN Pharm Biol; 2022 Dec; 60(1):509-524. PubMed ID: 35234563 [TBL] [Abstract][Full Text] [Related]
50. Phylogenetic Analysis and Structural Perspectives of RNA-Dependent RNA-Polymerase Inhibition from SARs-CoV-2 with Natural Products. Khan A; Khan M; Saleem S; Babar Z; Ali A; Khan AA; Sardar Z; Hamayun F; Ali SS; Wei DQ Interdiscip Sci; 2020 Sep; 12(3):335-348. PubMed ID: 32617855 [TBL] [Abstract][Full Text] [Related]
52. Medicinal Plants, Phytochemicals, and Herbs to Combat Viral Pathogens Including SARS-CoV-2. Anand AV; Balamuralikrishnan B; Kaviya M; Bharathi K; Parithathvi A; Arun M; Senthilkumar N; Velayuthaprabhu S; Saradhadevi M; Al-Dhabi NA; Arasu MV; Yatoo MI; Tiwari R; Dhama K Molecules; 2021 Mar; 26(6):. PubMed ID: 33809963 [TBL] [Abstract][Full Text] [Related]
53. Structure-based screening of natural product libraries in search of potential antiviral drug-leads as first-line treatment to COVID-19 infection. Rao SJA; Shetty NP Microb Pathog; 2022 Apr; 165():105497. PubMed ID: 35337962 [TBL] [Abstract][Full Text] [Related]
54. Natural Products-Derived Chemicals: Breaking Barriers to Novel Anti-HSV Drug Development. Treml J; Gazdová M; Šmejkal K; Šudomová M; Kubatka P; Hassan STS Viruses; 2020 Jan; 12(2):. PubMed ID: 32013134 [TBL] [Abstract][Full Text] [Related]
55. Bioactive Terpenes and Their Derivatives as Potential SARS-CoV-2 Proteases Inhibitors from Molecular Modeling Studies. Diniz LRL; Perez-Castillo Y; Elshabrawy HA; Filho CDSMB; de Sousa DP Biomolecules; 2021 Jan; 11(1):. PubMed ID: 33430299 [TBL] [Abstract][Full Text] [Related]
56. Antiviral potential of natural products from marine microbes. Yi M; Lin S; Zhang B; Jin H; Ding L Eur J Med Chem; 2020 Dec; 207():112790. PubMed ID: 32937282 [TBL] [Abstract][Full Text] [Related]
57. In silico evaluation of Philippine Natural Products against SARS-CoV-2 Main Protease. Cheng AJT; Macalino SJY; Billones JB; Balolong MP; Murao LAE; Carrillo MCO J Mol Model; 2022 Oct; 28(11):345. PubMed ID: 36205801 [TBL] [Abstract][Full Text] [Related]
58. A Photoactivable Natural Product with Broad Antiviral Activity against Enveloped Viruses, Including Highly Pathogenic Coronaviruses. Meunier T; Desmarets L; Bordage S; Bamba M; Hervouet K; Rouillé Y; François N; Decossas M; Sencio V; Trottein F; Tra Bi FH; Lambert O; Dubuisson J; Belouzard S; Sahpaz S; Séron K Antimicrob Agents Chemother; 2022 Feb; 66(2):e0158121. PubMed ID: 34807755 [TBL] [Abstract][Full Text] [Related]
59. Natural products for COVID-19 prevention and treatment regarding to previous coronavirus infections and novel studies. Boozari M; Hosseinzadeh H Phytother Res; 2021 Feb; 35(2):864-876. PubMed ID: 32985017 [TBL] [Abstract][Full Text] [Related]
60. Broad-Spectrum Antiviral Activity of 3D8, a Nucleic Acid-Hydrolyzing Single-Chain Variable Fragment (scFv), Targeting SARS-CoV-2 and Multiple Coronaviruses In Vitro. Lee G; Budhathoki S; Lee GY; Oh KJ; Ham YK; Kim YJ; Lim YR; Hoang PT; Lee Y; Lim SW; Kim JM; Cho S; Kim TH; Song JW; Lee S; Kim WK Viruses; 2021 Apr; 13(4):. PubMed ID: 33918914 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]